4. Conclusions
A number of different viral gene products are now known to interact with different TLR family members. In some cases, induction of the innate response may limit infection by different viruses, especially when the infectious dose is high. Because these receptors recognize elements of the virus that are highly conserved, instead of evolving to avoid this response, some viruses may have adapted to utilizing the response, as a means of facilitating entry or replication, producing gene products such as transcription factors that increase virus gene expression or by down-modulating or subverting subsequent antiviral immune responses. Future studies are likely to uncover more effects of virus-induced TLR activation on pathogenesis.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Belvin, M. P. and Anderson, K. V., 1996, A conserved signaling pathway: the Drosophila Toll-Dorsal pathway. Annu. Rev. Cell. Dev. Biol. 12:393–416
Akira, S., Takeda, K., and Kaisho, T., 2001, Toll-like receptors: critical proteins linking innate and acquired immunity. Nat. Immunol. 2:675–680
Medzhitov, R., 2001, Toll-like receptors and innate immunity. Nat. Rev. Immunol. 1:135–145
Nishiya, T. and DeFranco, A. L., 2004, Ligand-regulated chimeric receptor approach reveals distinctive subcellular localization and signaling properties of the Toll-like receptors. J. Biol. Chem. 279:19008–19017
Ahmad-Nejad, P., Hacker, H., Rutz, M., Bauer, S., Vabulas, R. M., and Wagner, H., 2002, Bacterial CpG-DNA and lipopolysaccharides activate Toll-like receptors at distinct cellular compartments. Eur. J. Immunol. 32:1958–1968
Heil, F., Hemmi, H., Hochrein, H., Ampenberger, F., Kirschning, C., Akira, S., Lipford, G., Wagner, H., and Bauer, S., 2004, Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8. Science 303:1526–1529
Latz, E., Schoenemeyer, A., Visintin, A., Fitzgerald, K. A., Monks, B. G., Knetter, C. F., Lien, E., Nilsen, N. J., Espevik, T., and Golenbock, D. T., 2004, TLR9 signals after translocating from the ER to CpG DNA in the lysosome. Nat. Immunol. 5:190–198
Akira, S. and Hemmi, H., 2003, Recognition of pathogen-associated molecular patterns by TLR family. Immunol. Lett. 85:85–95
Tabeta, K., Georgel, P., Janssen, E., Du, X., Hoebe, K., Crozat, K., Mudd, S., Shamel, L., Sovath, S., Goode, J., Alexopoulou, L., Flavell, R. A., Beutler, B., 2004, Toll-like receptors 9 and 3 as essential components of innate immune defense against mouse cytomegalovirus infection. Proc. Nat. Acad. Sci. USA 101:3516–3521
Sandor, F., Latz, E., Re, F., Mandell, L., Repik, G., Golenbock, D., Espevik, T., Kurt-Jones, E. A., and Finberg, R. W., 2003, Importance of extra-and intracellular domains of TLR1 and TLR2 in NFκB signaling. J. Cell Biol. 162:1099–1110
Poltorak, A., He, X., Smirnova, I., Liu, M.-Y., van Huffel, C., Ku, X., Birdwell, D., Alejos, E., Silva, M., Galanos, C., Freudenberg, M., Ricciarid-Castagnoli, P., Layton, B., and Beutler, B., 1998, Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 282:2085–2088
Qureshi, S. T., Lariviere, L., Leveque, G., Clermont, S., Moore, K. J., Gros, P., and Malo, D., 1999, Endotoxin-tolerant mice have mutations in Toll-like receptor 4 (Tlr4). J. Exp. Med. 189:615–625
Shimazu, R., Akashi, S., Ogata, H., Nagai, Y., Fukudome, K., Miyake, K., and Kimoto, M., 1999, MD-2, a molecule that confers lipopolysaccharide responsiveness on toll-like receptor 4. J. Exp. Med. 189:1777–1782
Ozinsky, A., Underhill, D. M., FOntenot, J. D., Hajjai, A. M., Smith, K. D., Wilson, C. B., Schroeder, L., and Aderem, A., 2000, The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between Toll-like receptors. Proc. Natl. Acad. Sci. USA 97:13766–13771
Hajjar, A. M., O’Mahony, D. S., Ozinsky, A., Underhill, D. M., Aderem, A., Klebanoff, S. J., and Wilson, C. B., 2001, Functional interactions between Toll-like receptor (TLR) 2 and TLR1 or TLR6 in reponse to phenol-soluble modulin. J. Immunol. 166:15–19
Medzhitov, R., Preston-Hurlburt, P., Kopp, E., Stadlen, A., Chen, C., Ghosh, S., and Janeway, C. A. Jr., 1998, MyD88 is an adaptor protein in the hToll/IL-1 receptor family signaling pathways. Mol. Cell. 2: 253–258
McGettrick, A. F. and O’Neill, L. A. J., 2004, The expanding family of MyD88-like adaptors in Toll-like receptor signal transduction. Mol. Immunol. 41:577–582
Yamamoto, M., Sato, S., Mori, K., Hoshino, K., Takeuchi, O., Takeda, K., and Akira, S., 2002, A novel Toll/IL-1 receptor domain-containing adapter that preferentially activates the IFN-β promoter in the Toll-like receptor signaling. J. Immunol. 169:6668–6672
Oshiumi, H., Matsumoto, M., Funami, K., Akazawa, T., and Seya, T., 2003, TICAM-1, an adaptor molecule that participates in Toll-like receptor 3-mediated interferon-β induction. Nature Immunol. 4:161–167
Kawai, T., Takeuchi, O., Fujita, T., Inoue, J.-I., Muhlradt, P. F., Sato, S., Hoshino, K., and Akira, S., 2001, Lipopolysaccharide stimulates the Myd88-independent pathway and results in activation of IFN-regulatory factor 3 and the expression of a subset of lipopolysaccharide-inducible genes. J. Immunol. 167:5887–5894
Hoshino, K., Kaisho, T., Iwabe, T., Takeuchi, O., and Shizuo, A., 2002, Differential involvement of IFN-ß in Toll-like receptor-stimulated dendritic cell activation. Int. Immunol. 14:1225–1231
Toshchakov, V., Jones, B. W., Perera, P. Y., Thomas, K., Cody, M. J., Zhang, S., Williams, B. R., Major, J., Hamilton, T. A., Fenton, M. J., and Vogel, S. N., 2002, TLR4, but not TLR2, mediates IFN-β-induced STAT1α/β-dependent gene expression in macrophages. Nat. Immunol. 3:392–398
Doyle, S. E., Vaidya, S. A., O’Connell, R., Dadgostar, H., Dempsey, P. W., Wu, T.-T., Rao, G., Sun, R., Haberland, M. E., Modlin, R. L., and Cheng, G., 2002, IRF3 mediates a TLR3/TLR4-specific antiviral gene program. Immunity 17:251–263
Sieling, P. A., Chung, W., Duong, B. T., Godowski, P. J., and Modlin, R. L., 2003, Tolllike receptor 2 ligands as adjuvants for human Th1 responses. J. Immunol. 170:194–200
Dabbagh, K., Dahl, M. E., Stepick-Biek, P., and Lewis, D. B., 2002, Toll-like receptor 4 is required for optimal development of Th2 immune responses: role of dendritic cells. J. Immunol. 168:4524–4530
Kaisho, T., Hoshino, K., Iwabe, T., Takeuchi, O., Yasui, Y., and Akira, A., 2002, Endotoxin can induce MyD88-deficient dendritic cells to support Th2 cell differentiation. Int. Immunol. 14:695–700
Barton, G. M. and Medzhitov, R., 2002, Control of adaptive immune responses by Toll-like receptors. Curr. Opin. Immunol. 14:380–383
Schnare, M., Barton, G. M., Holt, A. C., Takeda, K., Akira, S., and Medzhitov, R., 2001, Toll-like receptors control activation of adaptive immune responses. Nat. Immunol. 2:947–950
Graham, B. S., 1996, Immunological determinants of disease caused by respiratory syncytial virus. Trends Microbiol. 4:290–293
Connors, M., Giese, N. A., Kulkarni, A. B., Firestone, C.-Y., Holmes, K. L., Morse III, H. C., and Murphy, B. R., 1994, Enhanced pulmonary histopathology induced by respiratory syncytial virus (RSV) challenge of formalin-inactivated RSV-immunized BALB/c mice is abrogated by depletion of interleukin-4 (IL-4) and IL-10. J. Virol. 68:55321–5325
Waris, M. E., Tsou, C., Erdman, D. D., Zaki, S. R., and Anderson, L. J., 1996, Respiratory syncytial virus infection in BALB/c mice previously immunized with formalin-inactivated virus induces enhanced pulmonary inflammatory response with a predominant Th2-like cytokine pattern. J. Virol. 70:2852–2860
Becker, S., Quay, J., and Soukup, J., 1991, Cytokine (tumor necrosis factor, IL-6, and IL-8) production by respiratory syncytial virus-infected human alveolar macrophages. J. Immunol. 147:4307–4312
Tripp, R. A. and Anderson, L. J., 1998, Cytoxic T-lymphocyte precursor frequencies in BALB/c mice after acute respiratory syncytial virus (RSV) infection or immunization with a formalin-inactivated RSV vaccine. J. Virol. 72:8971–8975
Haeberle, H. A., Takizawa, R., Casola, A., Brasier, A. R., Dieterich, H. J., Van Rooijen, N., Gatalica, Z., and Garofalo, R. P., 2002, Respiratory syncytial virus-induced activation of nuclear factor-kappaB in the lung involves alveolar macrophages and toll-like receptor 4-dependent pathways. J. Infect. Dis. 186:1199–1206
Kurt-Jones, E. A., Popova, L., Kwinn, L., Haynes, L. M., Jones, L. P., Tripp, R. A., Walsh, E. E., Freeman, M. W., Golenbock, D. T., Anderson, L. J., and Finberg, R. W., 2000, Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus. Nat. Immunol. 1:398–401
Diebold, S. S., Kaisho, T., Hemmi, H., Akira, S., and Reis e Sousa, C., 2004, Innate antiviral responses by mean of TLR7-mediated recognition of single-stranded RNA. Science 303:1529–1531
Haynes, L. M., Moore, D. D., Kurt-Jones, E. A., Finberg, R. W., Anderson, L. J., and Tripp, R. A., 2001, Involvement of toll-like receptor 4 in innate immunity to respiratory syncytial virus. J. Virol. 75:10730–10737
Poltorak, A., Merlin, T., Nielsen, P. J., Sandra, O., Smirnova, I., Schupp, I., Boehm, T., Galanos, C., and Freudenberg, M. A., 2001, A point mutation in the IL-12R□2 gene underlies the IL-12 unresponsiveness of Lps-defective C57BL/10ScCr mice. J. Immunol. 167:2106–2111
Ehl, S., Bischoff, R., Ostler, T., Vallbracht, S., Schulte-Monting, J., Poltorak, A., and Freudenberg, M., 2004, The role of Toll-like receptor 4 versus interleukin-12 in immunity to respiratory syncytial virus. Eur. J. Immunol. 34:1146–1153
Tal, G., Mandelberg, A., Dalal, I., Cesar, K., Somekh, E., Tal, A., Oron, A., Itskovich, S., Ballin, A., Houri, S., Beigelman, A., Lider, O., Rechavi, G., and Amariglio, N., 2004, Association between common Toll-like receptor 4 mutations and severe respiratory syncytial virus disease. J. Infect. Dis. 189:2057–2063
Aberle, J. H., Aberle, S. W., Dworzak, M. N., Mandl, C. W., Rebhandl, W., Vollnhofer, G., Kundi, M., and Popow-Kraupp, T., 1999, Reduced interferon-gamma expression in a peripheral blood mononuclear cells of infants with severe respiratory syncytial virus disease. Am. J. Respir. Crit. Care Med. 160:1263–1268
Roman, M., Calhoun, W. J., Hinton, K. L., Avendano, L. F., Simon, V., Escobar, A. M., Gaggero, A., and Diaz, P. V., 1997, Respiratory syncytial virus infection in infants is associated with predominant Th-2-like response. Am. J. Respir. Crit. Care Med. 156:190–195
Becker, M. N., Diamond, G., Verghese, M. W., and Randell, S. H., 2000, CD14-dependent lipopolysaccharide-induced beta-defensin-2 expression in human tracheobronchial epithelium. J. Biol. Chem. 275:29731–29736
Ross, S. R., 2000, Using genetics to probe host-virus interactions: the mouse mammary tumor virus model. Microbes and Inf. 2:1215–1223
Outzen, H. C., Morrow, D., and Shultz, L. D., 1985, Attenuation of exogenous murine mammary tumor virus virulence in the C3H/HeJ mouse substrain bearing the Lps mutation. J. Natl. Canc. Inst. 75:917–923
Ardavin, C., Luthi, F., Andersson, M., Scarpellino, L., Martin, P., Diggelmann, H., and Acha-Orbea, H., 1997, Retrovirus-induced target cell activation in the early phases of infection: the mouse mammary tumor virus model. J. Virol. 71:7295–7299
Rassa, J. C., Meyers, J. L., Zhang, Y., Kudaravalli, R., and Ross, S. R., 2002, Murine retroviruses activate B cells via interaction with Toll-like receptor 4. Proc. Natl. Acad. Sci. USA 99:2281–2286
Burzyn, D., Rassa, J. C., Kim, D., Nepomnaschy, I., Ross, S. R., and Piazzon, I., 2004, Toll-like receptor 4-dependent activation of dendritic cells by a retrovirus. J. Virol. 78:576–584
Vogel, S. N., Johnson, D., Perera, P., Medvedev, A., Lariviere, L., Qureshi, S. T., and Malo, D., 1999, Functional characterization of the effect of the C3H/HeJ defect in mice that lack an Lpsn gene: In vivo evidence for a dominant negative mutation. J. Immunol. 162:5666–5670
Martin, P., Ruiz, S. R., Martinez del Hoyo, G., Anjuere, F., Vargas, H. H., Lopez-Bravo, M., and Ardavin, C., 2002, Dramatic increase in lymph node dendritic cell numbers during infection by the mouse mammary tumor virus occurs by a CD62L-dependent blood-borne DC recruitment. Blood 99:1282–1288
Vacheron, S., Luther, S. J., and Acha-Orbea, H., 2002, Preferential infection of immature dendritic cells and B cells by mouse mammary tumor virus. J. Immunol. 168:3470–3476
Harel, J., Rassart, E., and Jolicoeur, P., 1981, Cell cycle dependence of synthesis of unintegrated viral DNA in mouse cells newly infected with murine leukemia virus. Virol. 110:202–207
Roe, T., Reynolds, T. C., Yu, G., and Brown, P. O., 1983, Integration of murine leukemia virus DNA depends on mitosis. EMBO J. 12:2099–2108
Jude, B. A., Pobezinskaya, Y., Bishop, J., Parke, S., Medzhitov, R. M., Chervonsky, A. V., and Golovkina, T. V., 2003, Subversion of the innate immune system by a retrovirus. Nat. Immunol. 4:573–578
Hook, L. M., Agafonova, Y., Ross, S. R., Turner, S. J., and Golovkina, T. V., 2000, Genetics of mouse mammary tumor virus-induced mammary tumors: linkage of tumor induction to the gag gene. J. Virol. 74:8876–8883
Schneider-Schaulies, S. and ter Meulen, V., 2002, Triggering of and interference with immune activation: interactions of measles virus with monocytes and dendritic cells. Viral Immunol. 15:417–428
Schneider-Schaulies, S., Klagge, I. M., and ter Meulen, V., 2003, Dendritic cells and measles virus infection. Curr. Top. Microbiol. Immunol. 276:77–101
Schneider-Schaulies, J., Meulen, V., and Schneider-Schaulies, S., 2003, Measles infection of the central nervous system. J. Neurovirol. 9:247–252
Dorig, R. E., Marcil, A., Chopra, A., and Richardson, C. D., 1993, The human CD46 molecule is a receptor for measles virus (Edmonston strain). Cell 75:295–305
Tatsuo, H., Ono, N., Tanaka, K., and Yanagi, Y., 2000, SLAM (CDw150) is a cellular receptor for measles virus. Nature 406:893–897
Klagge, I. M. and Schneider-Schaulies, S., 1999, Virus interactions with dendritic cells. J. Gen. Virol. 80:823–833
Helin, E., Vainionpaa, R., Hyypia, T., Julkunen, I., and Matikainen, S., 2001, Measles virus activates NF-kappa B and STAT transcription factors and production of IFN-alpha/beta and IL-6 in the human lung epithelial cell line A549. Virology 290:1–10
Schnorr, J. J., Xanthakos, S., Keikavoussi, P., Kaempgen, E., ter Meulen, V., and Schneider-Schaulies, S., 1997, Induction of maturation of human blood dendritic cell precursors by measles virus is associated with immunosuppression. Proc. Natl. Acad. Sci. USA 94:5326–5331
Bieback, K., Lien, E., Klagge, I. M., Avota, E., Schneider-Schaulies, J., Duprex, W. P., Wagner, H., Kirschning, C. J., ter Meulen, V., and Schneider-Schaulies, S., 2002, Hemagglutinin protein of wild-type measles virus activates toll-like receptor 2 signaling. J. Virol. 76:8729–8736
Murabayashi, N., Kurita-Taniguchi, M., Ayata, M., Matsumoto, M., Ogura, H., and Seya, T., 2002, Susceptibility of human dendritic cells (DCs) to measles virus (MV) depends on their activation stages in conjunction with the level of CDw150: role of Toll stimulators in DC maturation and MV amplification. Microbes and Inf. 4:785–794
Zhu, H., Cong, J. P., and Shenk, T., 1997, Use of differential display analysis to assess the effect of human cytomegalovirus infection on the accumulation of cellular RNAs: induction of interferon-responsive RNAs. Proc. Natl. Acad. Sci. USA 94:13985–13990
Zhu, H., Cong, J. P., Mamtora, G., Gingeras, T., and Shenk, T., 1998, Cellular gene expression altered by human cytomegalovirus: global monitoring with oligonucleotide arrays. Proc. Natl. Acad. Sci. USA 95:14470–14475
Simmen, K. A., Singh, J., Luukkonen, B. G., Lopper, M., Bittner, A., Miller, N. E., Jackson, M. R., Compton, T., and Fruh, K., 2001, Global modulation of cellular transcription by human cytomegalovirus is initiated by viral glycoprotein B. Proc. Natl. Acad. Sci. USA 98:7140–7145
Compton, T., Kurt-Jones, E. A., Boehme, K. W., Belko, J., Latz, E., Golenbock, D. T., and Finberg, R. W., 2003, Human cytomegalovirus activates inflammatory cytokine responses via CD14 and Toll-like receptor 2. J. Virol. 77:4588–4596
Boehme, K. W., SIngh, J., Perry, S. T., and Compton, T., 2004, Human cytomegalovirus elicits a coordinated cellular antiviral response via envelope glycoprotein B. J. Virol. 78:1202–1211
Kurt-Jones, E. A., Chan, M., Zhou, S., Wang, J., Reed, G., Bronson, R., Arnold, M. M., Knipe, D. M., and Finberg, R. W., 2004, Herpes simplex virus 1 interaction with Toll-like receptor 2 contributes to lethal encephalitis. Proc. Natl. Acad. Sci USA 101:1315–1320
Sen, G. C., 2001, Viruses and interferons. Annu. Rev. Microbiol. 55:255–281
Hemmi, H., Takeuchi, O., Kawai, T., Kaisho, T., Sato, S., Sanjo, H., Matsumoto, M., Hoshino, K., Wagner, H., Takeda, K., and Akira, S., 2000, A Toll-like receptor recognizes bacterial DNA. Nature 408:740–745
Leadbetter, E. A., Rifkin, I. R., Hohlbaum, A. M., Beaudette, B. C., Shlomchik, M. J., and Marshak-Rothstein, A., 2002, Chromatin-IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors. Nature 416:603–607
Zhao, X. Y., Deak, E., Soderberg, K., Linehan, M., Spezzano, D., Zhu, J., Knipe, D. M., and Iwasaki, A., 2003, Vaginal submucosal dendritic cells, but not Langerhans’ cells, induce protective Th1 responses to herpes simplex virus-2. J. Exp. Med. 197:153–162
Lund, J., Sato, A., Akira, S., Medzhitov, R., and Iwasaki, A., 2003, Toll-like receptor 9-mediated recognition of Herpes simplex virus-2 by plasmacytoid dendritic cells. J. Exp. Med. 198:513–520
Krug, A., Luker, G. D., Barchet, W., Leib, D. A., Akira, S., and Colonna, M., 2004, Herpes simplex virus type 1 activates murine natural interferon-producing cells through Toll-like receptor 9. Blood 103:1433–1437
Karlin, S., Doerfler, W., and Cardon, L. R., 1994, Why is CpG suppressed in the genome of virtually all small eukaryotic viruses but not in those of large eukaryotic viruses? J. Virol. 68:2889–2897
Krmpotic, A., Bubic, I., Polic, B., Lucin, P., and Jonjic, S., 2003, Pathogenesis of murine cytomegalovirus infection. Microbes Infect. 5:1263–1277
Brown, M. G., Dokun, A. O., Heusel, J. W., Smith, H. R., Beckman, D. L., Blattenberger, E. A., Dubbelde, C. E., Stone, L. R., Scalzo, A. A., and Yokoyama, W. M., 2001, Vital involvement of a natural killer cell activation receptor in resistance to viral infection. Science 292:934–937
Lee, S. H., Girard, S., Macina, D., Busa, M., Zafer, A., Belouchi, A., Gros, P., and Vidal, S. M., 2001, Susceptibility to mouse cytomegalovirus is associated with deletion of an activating natural killer cell receptor of the C-type lectin superfamily. Nat. Genet. 28:42–45
Edelmann, K. H., Richardson-Burns, S., Alexopoulou, L., Tyler, K. L., Flavell, R. A., and Oldstone, M. B. A., 2004, Does Toll-like receptor 3 play a biological role in virus infections? Virol. 322:231–238
Seet, B. T., Johnston, J. B., Brunetti, C. R., Barrett, J. W., Everett, H., Cameron, C., Sypula, J., Nazarian, S. H., Lucas, A., and Grant McFadden, G., 2003, Poxviruses and immune evasion. Annu. Rev. Immunol. 21:377–423
Bowie, A., Kiss-Toth, E., Symons, J. A., Smith, G. L., Dower, S. K., and O’Neill, L. A., 2000, A46R and A52R from vaccinia virus are antagonists of host IL-1 and Toll-like receptor signaling. Proc. Natl. Acad. Sci. USA 97:10162–10167
Xu, Y., Tao, X., Shen, B., Horng, T., Medzhitov, R., Manley, J. L., and Tong, L., 2000, Structural basis for signal transduction by the Toll/interleukin-1 receptor domains. Nature 408: 111–115
Harte, M. T., Haga, I. R., Maloney, G., Gray, P., Reading, P. C., Bartlett, N. W., Smith, G. L., Bowie, A., and O’Neill, L. A., 2003, The poxvirus protein A52R targets Toll-like receptor signaling complexes to suppress host defense. J. Exp. Med. 197:343–351
Merchant, M., Caldwell, R. G., and Longnecker, R., 2000, The LMP2A ITAM is essential for providing B cells with development and survival signals in vivo. J. Virol. 74:9115–9124
DiPerna, G., Stack, J., Bowie, A. G., Boyd, A., Kotwal, G., Zhang, Z., Arvikar, S., Latz, E., Fitzgerald, K. A., and Marshall, W. L., 2004, Poxvirus protein N1L targets the I-κB kinase complex, inhibits signaling to NF-κB by the tumor necrosis factor superfamily of receptors, and inhibits NF-κB and IRF3 signaling by Toll-like receptors. J. Biol. Chem. in press.
van den Broek, M. F., Muller, U., Huang, S., Zinkernagel, R. M., and Aguet, M., 1995, Immune defense in mice lacking type I and/or type II interferon receptors. Immunol. Rev. 148:5–18
Engelmayer, J., Larsson, M., Subklewe, M., Chahroudi, A., Cox, W. I., Steinman, R. M., and Bhardwaj, N., 1999, Vaccinia virus inhibits the maturation of human dendritic cells: a novel mechanism of immune evasion. J. Immunol. 163:6762–6768
Hoebe, K., Du, X., Georgel, P., Janssen, E., Tabeta, K., Kim, S. O., Goode, J., Lin, P., Mann, N., Mudd, S., Crozat, K., Sovath, S., Han, J., and Beutler, B., 2003, Identification of Lps2 as a key transducer of MyD88-independent TIR signalling. Nature 424:743–748
Akula, S. M., Naranatt, P. P., Walia, N. S., Wang, F. Z., Fegley, B., and Chandran, B., 2003, Kaposi’s sarcoma-associated herpesvirus (human herpesvirus 8) infection of human fibroblast cells occurs through endocytosis. J. Virol. 77:7978–7990
Nicola, A. V., McEvoy, A. M., and Straus, S. E., 2003, Roles for endocytosis and low pH in herpes simplex virus entry into HeLa and Chinese hamster ovary cells. J. Virol. 77:5324–5332
Alexopoulou, L., Holt, A. C., Medzhitov, R., and Flavell, R. A., 2001, Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature. 413:732–738
Honda, K., Sakaguchi, S., Nakajima, C., Watanabe, A., Yanai, H., Matsumoto, M., Ohteki, T., Kaisho, T., Takaoka, A., Akira, S., Seya, T., and Taniguchi, T., 2003, Selective contribution of IFN-alpha/beta signaling to the maturation of dendritic cells induced by double-stranded RNA or viral infection. Proc. Natl. Acad. Sci. USA 100:10872–10877
Lund, J. M., Alexopoulou, L., Sato, A., Karow, M., Adams, N. C., Gale, N. W., Iwasaki, A., and Flavell, R. A., 2004, Recognition of single-stranded RNA viruses by Toll-like receptor 7. Proc. Natl. Acad. Sci. USA 101:5598–5603
Hemmi, H., Kaisho, T., Takeuchi, O., Sato, S., Sanjo, H., Hoshino, K., Horiuchi, T., Tomizawa, H., Takeda, K., and Akira, S., 2002, Small antiviral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway. Nat. Immunol.. 3:196–200
Heil, F., Ahmad-Nejad, P., Hemmi, H., Hochrein, H., Ampenberger, F., Gellert, T., Dietrich, H., Lipford, G., Takeda, K., Akira, S., Wagner, H., and Bauer, S., 2003, The Toll-like receptor 7 (TLR7)-specific stimulus loxoribine uncovers a strong relationship within the TLR7, 8 and 9 subfamily. Eur. J. Immunol. 33:2987–2997
Hernandez, L. D., Hoffman, L. R., Wolfsberg, T. G., and White, J. M., 1996, Virus-cell and cell-cell fusion. Annu. Rev. Cell. Dev. Biol. 12:627–661
Skehel, J. J. and Wiley, D. C., 2000, Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin. Annu. Rev. Biochem. 69:531–569
Equils, O., Faure, E., Thomas, L., Bulut, Y., Trushin, S., and Arditi, M., 2001, Bacterial lipopolysaccharid activates HIV long terminal repeat through toll-like receptor 4. J. Immunol. 166:2342–2347
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2005 Springer
About this chapter
Cite this chapter
Ross, S.R. (2005). Viral Pathogenesis and Toll-Like Receptors. In: Palese, P. (eds) Modulation of Host Gene Expression and Innate Immunity by Viruses. Springer, Dordrecht. https://doi.org/10.1007/1-4020-3242-0_10
Download citation
DOI: https://doi.org/10.1007/1-4020-3242-0_10
Publisher Name: Springer, Dordrecht
Print ISBN: 978-1-4020-3241-7
Online ISBN: 978-1-4020-3242-4
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)